Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • Opinion

    Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight

    No doubt, after many weeks with coronavirus, dubbed “COVID-19”, lingering in the background of U.S and Australian corporate reporting season, investment markets, have reacted strongly over the past week. On public health concerns and uncertainty over the economic impact, we saw a sell-off in equities and yield on “safe-haven” 10-year Treasuries being pushed to record

    Read More
    Public
  • New ASX listing Founders First acquires award winning Kangaroo Island Distillery
    • News

    New ASX listing Founders First acquires award winning Kangaroo Island Distillery

    Following the company’s successful $15 million IPO capital raising, Australian craft beverage company Founders First (ASX: FFL) has announced the acquisition of Kangaroo Island Distillery (KIS) for $1.5 million. The company has been busy since listing back in December 2019, with similar sized acquisitions in Hunter Valley and Moonee Ponds, and a significant convertible note

    Read More
    Public
  • Being defensive is currently paying off…
    • Opinion

    Being defensive is currently paying off…

    Given so many coronavirus experts have appeared since its outbreak, we haven’t felt the need to add to the noise. But we have been closely monitoring the situation through macro data, bottom up company research, discussions with company management teams, with our partners here and offshore. The recent offshore and current ASX reporting season has

    Read More
    Public
  • Zoono successfully tests against coronavirus COVID-19, shares skyrocket
    • News

    Zoono successfully tests against coronavirus COVID-19, shares skyrocket

    Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

    Read More
    Public
  • Little Green Pharma to supply medicinal cannabis to underserviced German market
    • News

    Little Green Pharma to supply medicinal cannabis to underserviced German market

    Australian medicinal cannabis and healthcare company Little Green Pharma (ASX: LGP) has this morning announced a key purchase agreement with Berlin-based DEMECAN for the sale and export of up to 1000kg of dried cannabis flower or 48,000 units of medicinal cannabis per annum. The agreement makes LGP one of the first few companies to export

    Read More
    Public
  • With trade stalling in China, Eagle Health turns to Africa with new continental distributor
    • News

    With trade stalling in China, Eagle Health turns to Africa with new continental distributor

    As fears over the coronavirus outbreak continue to spread, health and nutritional product manufacturer Eagle Health (ASX: EHH) is set to diversify their distribution channels by entering a collaborative agreement with Amka Products which has a continental footprint throughout Africa.  The agreement will see AMKA, a market leader for manufacturing and distribution of health products

    Read More
    Public
  • «
  • ‹
  • 626
  • 627
  • 628
  • 629
  • 630
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.